Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Itron (ITRI) Change in Accured Expenses: 2009-2025

Historic Change in Accured Expenses for Itron (ITRI) over the last 17 years, with Sep 2025 value amounting to $4.1 million.

  • Itron's Change in Accured Expenses rose 139.43% to $4.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$27.1 million, marking a year-over-year decrease of 131.63%. This contributed to the annual value of -$35.4 million for FY2024, which is 179.17% down from last year.
  • As of Q3 2025, Itron's Change in Accured Expenses stood at $4.1 million, which was down 70.43% from $13.8 million recorded in Q2 2025.
  • Itron's Change in Accured Expenses' 5-year high stood at $77.3 million during Q3 2022, with a 5-year trough of -$77.1 million in Q2 2024.
  • In the last 3 years, Itron's Change in Accured Expenses had a median value of $4.1 million in 2025 and averaged -$2.0 million.
  • In the last 5 years, Itron's Change in Accured Expenses soared by 383.37% in 2022 and then plummeted by 1,169.75% in 2024.
  • Itron's Change in Accured Expenses (Quarterly) stood at $58.0 million in 2021, then crashed by 117.14% to -$9.9 million in 2022, then skyrocketed by 374.85% to $27.3 million in 2023, then tumbled by 86.59% to $3.7 million in 2024, then soared by 139.43% to $4.1 million in 2025.
  • Its Change in Accured Expenses was $4.1 million in Q3 2025, compared to $13.8 million in Q2 2025 and -$48.7 million in Q1 2025.